We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Provides Guidance on Nonclinical Studies for Drug Combinations
FDA Provides Guidance on Nonclinical Studies for Drug Combinations
January 25, 2005
The FDA released a draft guidance Jan. 25 providing recommendations on nonclinical safety evaluations to support the clinical study and approval of drug combinations, including fixed dose combination products, co-packaged products and adjunctive therapies.